doi: 10.1038/srep35452 141 ZhangB.YangR
We also demonstrated that cARLA treatment improved the predictive value of a human stem cell derived co-culture BBB model not only for small molecule drugs but also for targeted nanoparticles [40]
Manufactured for: Revised: November 2025 PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Vial Label - 1 mL: NDC 87188-111-01 Rx Only Cyanocobalamin Injection, USP 1,000 mcg/mL For Intramuscular or Subcutaneous Use Only 1 mL Multiple-Dose Vial Carton Label - 1 mL: NDC 87188-111-90 Rx Only Cyanocobalamin Injection, USP 1,000 mcg/mL For Intramuscular or Subcutaneous Use Only 25 X 1 mL Multiple-Dose Vials Vial Label - 10 mL: NDC 87188-112-01 Rx Only Cyanocobalamin Injection, USP 10,000 mcg/10 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 10 mL Multiple-Dose Vial Carton Label - 10 mL: NDC 87188-112-01 Rx Only Cyanocobalamin Injection, USP 10,000 mcg/10 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 1 x 10 mL Multiple-Dose Vial Vial Label - 30 mL: NDC 87188-113-01 Rx Only Cyanocobalamin Injection, USP 30,000 mcg/30 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 30 mL Multiple-Dose Vial Carton Label - 30 mL: NDC 87188-113-01 Rx Only Cyanocobalamin Injection, USP 30,000 mcg/30 mL (1,000 mcg/mL) For Intramuscular or Subcutaneous Use Only 1 x 30 mL Multiple-Dose Vial More about cyanocobalamin Check interactions Compare alternatives Pricing & coupons Reviews (31) Drug images Side effects Dosage information During pregnancy Drug class: vitamins
If you take metformin or long-term acid-reducing medications, these can lower B12 discuss monitoring with your practitioner
Earlier this month, Reuters reported that Acting FDA Commissioner Kyle Diamantas met with representatives of rare disease groups in a bid to fix relationships after they soured under former FDA Commissioner Marty Makary when FDA declined to approve several rare disease treatments
The findings revealed significant changes in the levels of ferroptosis-related markers, intracellular iron, and lipid peroxidation in corneal epithelial cells in a hyperosmotic injury model
